Comparative Pharmacognostical and Analytical Evaluation of Desmodium gangeticum (Linn.) and Pseudarthria viscida (Linn.) Wight & Arn. as a Substitute

Authors

  • Vijayalaxmi P.B. Guide, Professor, P.G. Studies in Department of Dravya Guna Vijanana, KVG Ayurveda Medical College and Hospital, Sullia, Karnataka, India
  • Reena Reena P.G. Scholar, P.G. Studies, Department of Dravya Guna Vijanana, KVG Ayurveda Medical College and Hospital, Sullia, Karnataka, India

Keywords:

carbohydrates, calcium crystals, glycoside, madhurarasa, steroids, tannin, tiktarasa

Abstract

Shalaparni [Desmodium gangeticum (Linn)] is one among the Dashamoola and Pseudarthria viscida (Linn) is used as a substitute instead of Shalaparni in south India especially Kerala state. Macroscopic, microscopic and organoleptic results of the standard drug D. gangeticum (Linn.) and trail drug P. viscida (Linn.) Wight & Arn., when compared with each other with Ayurveda Pharmacopoeia of India showed no much difference. D. gangeticum (Linn.) has more of calcium crystals and stone cells as seen in Powder microscopy, while P, viscida (Linn.) Wight & Arn. also contain crystals of calcium oxalate and presence of colouring pigments. Taste determination of P. viscida (Linn.) Wight & Arn. by ‘Taste with Tongue Method’ was found to be Madhura Rasa pradhana Tikta Anurasa and that of D. gangeticum (Linn.) to be Tikta Rasa pradhana Madhura Anurasa. Phytochemical study showed the presence of carbohydrates, glycoside, tannin, steroids and phenol in both. By physicochemical study, it was observed that 8.27% water-soluble extract and 6.86% of alcohol-soluble extract was more in D. gangeticum (Linn.) than P. viscida (Linn.) Wight & Arn. that is 5.48% water extract and 3.59% alcohol extract. This substantiated that the trail drug can be used as a substitute for Shalaparni.

Author Biography

  • Vijayalaxmi P.B., Guide, Professor, P.G. Studies in Department of Dravya Guna Vijanana, KVG Ayurveda Medical College and Hospital, Sullia, Karnataka, India
    Department of Dravyaguna

References

Vaidya B. Some Controversial Drugs in Indian Medicine, 3rd Edition. Varanasi, India: Chaukhambha Orientalia; 2010. 226p, 262p, 231p.

Kritikar KR, Basu BD. Indian Medicinal Plants, 2nd Edition. DehraDun: International Book Distributors; 2008. 748p, 758–760p.

Nadkarni KM. K.M. Nadkarni’s Indian Materia Medica Volume-1. Bombay

Popular Prakashan; 1996. 445p, 612p, 1017p.

Anonymous. Wealth of India (A Dictionary of Indian Raw materials and Industrial Products) Volume-3, D-I. New Delhi, India: National Institute of Science Communication and Information Resources (CSIR); 2002. 19p.

Yooganarasimhan. Plants of India (Tamil Nadu) Volume-2.. Bangalore, India: Interline Publications; 2000. 189p, 446p, 566–567p.

Prajapati ND, Purohit SS, Sharma AK, Kumar T. A Hand Book of Medicinal Plants, Section -2. Delhi, India: MLBD; 2004. 194p, 427p.

Khandelwal KR. Practical Pharmacognosy, 13th ed. New Delhi, India: Nirali Prakashan; 2005. 157–160p.

Government of India. The Ayurvedic Pharmacopoeia of India; Part I, Vol II. 1st ed. New Delhi: Ministery of Health and Family Welfare, Government of India; 1999. 214p.

Agnivesha. Charaka Samhitha, English translation by Ram Karan Sharma and Bhagwan Dash, Sutra Sthana 26/13. Varanasi, India: Chaukhamba Sanskrit Series Office; 2007. 453p.

Dhyani SC. Rasa Panchaka (Ayurvedic Principles of Drug Action), 2nd Chap. Varanasi, India: Krishna Das Academy; 1994. 43p.

Lavekar GS, Padhi MM, Pant P, et al. Laboratory guide for the analysis. In: Turner RA, Editor. Screening methods in pharmacology, Vol 2. USA: Academic Press Ltd.; 1965.

Acharya Agnivesha. Charaka Samhita, English translation by Ram Karan Sharma and Bhagwan Dash, Vol.1, Sutra sthana 26/46- 47,. Varanasi, India: Chaukhamba Sanskrit Series Office; 2002. 470p.

Downloads

Published

2020-12-30

Issue

Vol. 7 No. 3 (2020)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.